semaglutide tirzepatide weight loss as Compared with for the Treatment of Obesity Semaglutide vs. Tirzepatide for weight
Description
Inform your provider of all medications, supplements, and herbal products you take
10.1172/JCI116186
Tirzepatide, the first dual GIP/GLP-1 receptor agonist (RA), received US Food and Drug Administration (FDA) approval for the treatment of T2DM in May 2022 and for chronic weight management in November 2023 [4]
They also explain why the regulatory landscape became so contentious
Month 1 (2.2mg): Starting dose $368
The risk increases further if tirzepatide causes mild nausea or food aversions, which prompt patients to avoid certain food groups
